文献速递腹部技术与安全US

在埃塞俄比亚南部建立手持超声设备筛查慢性肝病的方案:一项试点项目

Establishing an Ultrasound Screening Protocol for Chronic Liver Disease with a Handheld Device: A Pilot Project in Southern Ethiopia.
PubMed 文献 · Ultrasound Med Biol · 2022-01-31

该试点项目在埃塞俄比亚南部农村社区建立并实施了一套基于手持超声设备的慢性肝病筛查方案,采用已确立诊断准确性的评分系统评估肝纤维化/肝硬化和肝脂肪变,并纳入肝肿块、门静脉增宽、肝脏大小和脾脏大小的识别。94名参与者中肝脂肪变常见(49%,46/94),肝纤维化仅见于14%(13/94),平均检查时间约6分钟。该方案在资源有限地区可行,但无法用活检或其他横断面影像验证结果是方法学的重要局限。

要点

  • 手持超声可用于偏远地区慢性肝病筛查,平均检查时间约6分钟。
  • 94名参与者中肝脂肪变49%(46/94),肝纤维化14%(13/94)。
  • 方案基于已确立准确性的肝纤维化/肝硬化及肝脂肪变评分系统。

核心结论

  • 使用手持超声在偏远地区筛查慢性肝病是可行的,该项目为该领域进一步研究提供了循证框架。

研究设计与样本

  • 试点项目,在埃塞俄比亚南部农村社区实施,共94名参与者,使用手持超声设备,采用已确立诊断准确性的评分系统评估肝纤维化/肝硬化和肝脂肪变,并识别肝肿块、门静脉增宽、肝脏大小和脾脏大小;未使用活检或其他横断面影像作为参考标准验证。

关键影像表现/征象

  • 肝脂肪变常见,见于46/94名参与者(49%)。
  • 肝纤维化仅见于13/94名参与者(14%)。
  • 方案纳入肝肿块、门静脉增宽、肝脏大小和脾脏大小的识别。

诊断标准与关键数值

  • 采用已确立诊断准确性的评分系统诊断肝纤维化/肝硬化和肝脂肪变,原文未报告具体评分阈值、敏感度、特异度或AUC数值。

临床应用与阅片要点

  • 手持超声可用于偏远地区慢性肝病筛查,平均检查时间约6分钟。
  • 筛查方案包括评估肝脂肪变、肝纤维化/肝硬化、肝肿块、门静脉增宽、肝脏大小和脾脏大小。

局限性

  • 方法学的重要局限是无法用活检或其他横断面影像验证结果。
  • 该问题及当地卫生服务健康负担的患病率尚不明确。
  • 项目为试点项目,原文指出为在该领域进一步研究提供循证框架。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Chronic liver disease (CLD) poses significant challenges in the developing world. The prevalence of this problem and the health burden on local health services are not well understood. The diagnosis and monitoring of CLD are difficult in these settings because of limited access to expensive imaging with limited mobility and/or liver biopsy. The aim of this project was to develop and implement an efficient evidence-based robust ultrasound protocol for the assessment of chronic liver disease using a hand-held ultrasound device that could be effectively used in the developing world. A protocol was established using scoring systems that have established accuracy for the diagnosis of hepatic fibrosis/cirrhosis and hepatic steatosis. Included in the protocol was the identification of hepatic masses, portal venous enlargement, hepatic size and splenic size. Hepatic steatosis was common, identified in 46 of 94 participants (49%). Hepatic fibrosis was observed in only 13 of 94 participants (14%). A significant limitation of the methodology was the inability to validate the results with biopsy or other forms of cross-sectional imaging. The protocol was successfully implemented in a community in a rural setting in South Ethiopia with a mean examination time of around 6 min. It is feasible to use handheld ultrasound for the screening of CLD in remote settings. This project provides an evidence-based framework for further studies in this area.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Coombs, Warsa, Hailu, et al. Establishing an Ultrasound Screening Protocol for Chronic Liver Disease with a Handheld Device: A Pilot Project in Southern Ethiopia. Ultrasound Med Biol. 2022. PMID: 35105496. doi:10.1016/j.ultrasmedbio.2021.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。